HIV AIDS News [International Conference on AIDS (12th: 1998: Geneva, Switzerland)]
CRIXIVAN S(indinavir sulfate) STOCRINM (e fa viren z) Key Abstracts 12th World AIDS Conference June 28 Geneva, - July 3, 1988 Switzerland MERCK +Trademarks of MERCK & CO., Inc., Whitehouse Station, N.J., U.S.A. STOCRIN is the MSD brand name for efavirenz. STOCRIN is a non-nucleoside reverse transcriptase inhibitor under investigation for the treatment of HIV STOCRIN is not currently registered in Switzerland. A New Drug Application for efavirenz was filed with the U.S. FDA. STOCRIN is available for limited use only through clinical trials and an expanded access program. For more information, contact a representative of MSD.
About this Item
- Title
- HIV AIDS News [International Conference on AIDS (12th: 1998: Geneva, Switzerland)]
- Author
- Merck & Co.
- Canvas
- Page 1 - Title Page
- Publication
- 1998-06
- Subject terms
- press kits
- Series/Folder Title
- Chronological Files > 1998 > Events > International Conference on AIDS (12th : 1998 : Geneva, Switzerland) > Drug company materials
- Item type:
- press kits
Technical Details
- Collection
- Jon Cohen AIDS Research Collection
- Link to this Item
-
https://name.umdl.umich.edu/5571095.0147.018
- Link to this scan
-
https://quod.lib.umich.edu/c/cohenaids/5571095.0147.018/3
Rights and Permissions
The University of Michigan Library provides access to these materials for educational and research purposes, with permission from their copyright holder(s). If you decide to use any of these materials, you are responsible for making your own legal assessment and securing any necessary permission.
Related Links
IIIF
- Manifest
-
https://quod.lib.umich.edu/cgi/t/text/api/manifest/cohenaids:5571095.0147.018
Cite this Item
- Full citation
-
"HIV AIDS News [International Conference on AIDS (12th: 1998: Geneva, Switzerland)]." In the digital collection Jon Cohen AIDS Research Collection. https://name.umdl.umich.edu/5571095.0147.018. University of Michigan Library Digital Collections. Accessed May 11, 2025.